The producer is now able to transform pluripotent stem cells through its Opti-Ox technology into fat and muscle tissue in four days, down from eight days, which it claimed was faster than any other process in the industry.
By cutting cell differentiation time in half, Meatable’s process now requires nearly half as many bioreactors at scale, cutting CAPEX costs and enabling a more efficient use of production space.
Less labour, energy and infrastructure
This – coupled with the need for less labour, energy, infrastructure, ingredients and water – means the process has become more scalable and cost-efficient. Meatable also claimed the improvements make the process more sustainable.
Daan Luining, co-founder and chief technical officer of Meatable, said: “This is truly a remarkable moment for Meatable and the cultivated meat industry as a whole, as we just made the fastest process in the industry that much faster.
“Achieving the ability to produce cultivated meat at scale and efficiency has been our goal from day one and this step moves us significantly forward in fulfilling our promise.
‘Cost efficient at scale’
“Meatable remains intensely focused on providing the world with a real meat solution without harming animals or the environment and I’m proud to say that the reduction in cell differentiation time puts us on path to delivering our products cost efficient at scale.”
Meatable was also the first cultivated meat company to submit a dossier to the Dutch government for consideration to hold the first cultivated tastings in Europe, and continues to plan for expansion to the United States in 2025.
Meanwhile, Meatly has created the ‘world’s first’ cans of pet food that uses cultivated chicken as a protein source, ready for rollout to stores across the UK pending regulatory approval.
The new product was developed in collaboration with alternative protein pet-food manufacturer Omni, which produces dog food made from pulse, algae and yeast protein.
